Summary
This paper reviews the diagnostic role of monoclonal antibody immunohistochemistry in a series of 189 brain tumour biopsies and 22 cases of neoplastic meningitis. The diagnostic monoclonal antibody panel, which includes markers for glial, neural, epithelial and lymphoid differentiation antigens, was used to test a wide variety of cerebral and spinal tumours by indirect immunofluorescence and immunoperoxidase techniques on unfixed frozen sections. Gliomas, meningiomas, schwannomas, medulloblastomas, choroid plexus tumours, cerebral lymphomas and metastatic carcinomas could all be reliably differentiated by means of their characterisctic antigenics profiles, as defined by their patterns of reactivity with the antibody panel. Confident diagnosis was possible even in very poorly differentiated tumours and in biopsies distorted by surgical squeeze artefact, where paucity of morphological clues made diagnosis by conventional histological methods difficult or impossible. It was estimated that use of the antibody panel was responsible for, or made a significant contribution towards the final diagnosis in approximately 20% of cases.
The monoclonal reagents were also found to be of great value in the detection and characterisation of neoplastic cells in CSF specimens from patients with malignant meningitis. Malignant cells were detected in 73% of cases and characterised in 16% of cases by routine cytological techniques. Employing monoclonal immunocytology however, these figures were improved to 95% and 95% respectively. Our findings suggest that patients with neoplastic meningtitis can be spared prolonged investigation and inappropriate management by the early detection and characterisation of malignant cells in CSF using panels of monoclonal antibodies.
Similar content being viewed by others
References
Russell DS, Rubinstein LJ: Pathology of tumours of the nervous system. Edward Arnold, 4th Edition, London, 1977.
Pizzolo G, Sloane J, Beverley P, Thomas JA, Bradstock KF, Mattingly S, Janossy G: Differential diagnosis of malignant lymphoma and non-lymphoid tumours using monoclonal anti-leukocyte antibody. Cancer 46: 2640–2647, 1980.
Gatter KC, Abdulaziz K, Beverley PCL, Corvalon JRF, Ford C, Lane EB: Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Path 35: 1253–1267, 1982.
Bigner SH, Johnston WW: Cytopathology of cerebrospinal fluid. Acta Cytol 25: 461–479, 1981.
Heyderman E: Immunoperoxidase technique in histopathology: applications, methods and controls. J Clin Path 32: 971–978, 1979.
Garson JA: The development and characterisation of monoclinal antibodies for use in neuropathology. MD Thesis, University of Birmingham, 1983.
Robbins SL, Cotran RS: Pathologic basis of disease. WB Saunders Co, 2nd Edition, 1979, p 870.
Eng LF, Rubinstein LJ: Contribution of GFAP immunohistochemistry to diagnostic problems of human cerebral tumours. J Histochem Cystochem 26: 513, 1978.
Coakham HB, Garson JA, Brownell DB, Kemshead JT: Monoclonal antibodies as reagents for brain tumour diagnosis: a review. J Roy Soc Med 77, 780–787, 1984.
Coakham HB, Garson JA, Brownell DB, Allan PM, Harper El, Kemshead JT: The use of monoclonal antibodies in the immunohistological diagnosis of cerebral and spinal tumours. South African J Surg 22 (1): 13–22, 1984.
Coakham HB, Garson JA, Allan PM, Harper El, Brownell DB, Kemshead JT, Lane EB: The immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel. J Clin Path (in press) 1985.
Milstein C, Galfre G, Secher DS, Springer T: Monoclonal antibodies and cell surface antigens. Cell Biol Int Rep 3 (1): l, 1979.
Greaves MF: Monoclonal antibodies as probes for leukaemic heterogeneity and haemopoetic differentiation. In: Leukaemia Markers, 1 st Edition, Knapp W led), Academic Press, 1981, p 26.
Ghadially FN: The role of electron microscopy in the determination of tumour histogenesis. Diagnostic Histopath 4: 245–262, 1981.
Rio-Hortega P del: Tumours of the coverings of the brain and of the spinal cord. In: The Microscopic Anatomy of Tumours of the Central and Peripheral Nervous System, Chap. 5, 1st Edition, Charles Thomas, USA, 1962.
Bartlett PF, Noble MD, Pruss RM, Raff MC, Rattray S, Williams CA: Rat neural antigen-2 (RAN-2): A cell surface antigen on astrocytes, ependymal cells, Muller cells and leptomeninges defined by a monoclonal antibody. Brain Res 204: 339–351, 1981.
Le Gros Clark, Sir WE: The Tissues of the Body, 6th Edition, Oxford University Press, 1971, p 339.
Van Der Meulen JDM, Houthoff HJ, Ebels EJ: Glial fibrillary acidic protein in human gliomas. Neuropath and Applied Neurobiol 4: 177–190, 1978.
Cammins MB, Cravioto HM, Epstein F, Ransohoff J: Medulloblastoma: an ultrastructural study - evidence for glial and neuronal differentiation. Neurosurgery 6: 398–477, 1980.
Rorke LB: The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumours. J Neuropathol Exp Neurol 42: 1–15, 1983.
Malpas JF, Kemshead JT, Pritchard J, Greaves MF: Heterogeneity in antigenic expression on neuroblastoma cells detected by monoclonal antibodies. Paediatric Oncology, (eds) Clement R, Lebreuil G, Bernard J, Excerpta Medica, Amsterdam, 1982, pp 90–95.
Coakham HB, Garson JA, Brownell DB, Allan PM, Harper EL Lane EB, Kemshead JT: Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet 8386: 1095–1098, 1984.
Coakham HB, Harper El, Garson JA, Brownell DB, Lane EB: Carcinomatous meningitis diagnosed with monoclonal antibodies. Brit Med J 288: 1272, 1984.
Ghosh AK, Spriggs AI, Taylor-Papadimitriou J, Mason DY: Immunocytological staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. J Clin Path 36: 1154–1164, 1983.
Makin CA, Borrow LG, Bodmer WF: A monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Path 37 (9): 978–983, 1984.
Warnke RA, Gatter KC, Falini B: The diagnosis of human lymphoma using monoclonal anti-leukocyte anitbodies. N Eng J Med 309: 1275–1281, 1984.
Allan PM, Garson JA, Harper El, Coakham HB, Brownell DB, Kemshead JT: Biological characterisation and clinical applications of a monoclonal antibody recognising an antigen restricted to neuroectodermal tissues. Int J Cancer 31: 591–598, 1983.
Kemshead JT, Fritschy J, Garson JA, Allan PM, Coakham HB, Brown S, Asser U: UJ 127.11 detects a 220-240,000 Mot. Wt. glycoprotein present on a subset of neuroectodermally derived cells. Int J Cancer 31: 187–195, 1983.
Lane EB: Monoclonal antibodies procide specific intramolecular markers for the study of epithelial tonofilament organisation. J Cell Biol 92: 665–673, 1982.
Garson JA, Beverley PCL, Coakham HB, Harper El: Monoclinal antibodies against human T lymphocytes label Purkinje neurones of many species. Nature 289 (5782), 375–377, 1982.
Nadler LM, Ritz J, Hardy R, Pesander JM, Schlossman SF: A unique cell surface antigen identifying lympboid malignancies of B cell origin. J Clin Invest 67: 134–140, 1981.
Arklie J: Studies of the human epithelial cell surface using monoclonal antibodies. D Phil Thesis, University of Oxford, 1981.
Anderton BH, Breinburg D, Downes MJ: Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature 298: 84–86, 1982.
Morgan ACJ, Gallaway DR, Reisfeld RA: Production and characterisation of monoclonal antibody to a melanomaspecific glycoprotein. Hybridoma 1: 27, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garson, J.A., Coakham, H.B., Kemshead, J.T. et al. The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology. J Neuro-Oncol 3, 165–171 (1985). https://doi.org/10.1007/BF02228893
Issue Date:
DOI: https://doi.org/10.1007/BF02228893